Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

Nobel Biocare N1 TiUltra TCC RP 4.8x9mm: medical device reports filed with FDA

382 reports name it, 2023–2026. Manufacturer given most often on reports: Nobel Biocare G Teborg. Product code DZE.

382
device reports naming the brand
0% of all MAUDE reports · about 127 a year
190
reports, 12 months to August 2026
146 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

382 medical device reports received by FDA name the brand "Nobel Biocare N1 TiUltra TCC RP 4.8x9mm" (endosseous dental implant); the manufacturer given most often on reports is Nobel Biocare G Teborg; received from July 2023 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

190 reports arrived in the 12 months to August 2026, up 30% from 146 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (64.4%), loss of osseointegration (23.6%) and osseointegration problem (6.8%). The patient problems coded most often are failure of implant, implant pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02244Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 2Aug 2023: 2Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 6Mar 2024: 2Apr 2024: 2May 2024: 8Jun 2024: 8Jul 2024: 10Aug 2024: 6Sep 2024: 8Oct 2024: 8Nov 2024: 8Dec 2024: 202025Jan 2025: 22Feb 2025: 12Mar 2025: 12Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 42Aug 2025: 14Sep 2025: 12Oct 2025: 8Nov 2025: 26Dec 2025: 162026Jan 2026: 2Feb 2026: 12Mar 2026: 16Apr 2026: 20May 2026: 10Jun 2026: 14Jul 2026: 44Aug 2026: 10

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0821642023: 420232024: 8620242025: 16420252026: 1282026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%382
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%191
Voluntary report0%0
User facility report0%0
Distributor report50%191
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate24664.4%62.8%
Loss of osseointegration9023.6%22.4%
Osseointegration problem266.8%7.7%
Migrationthe device moved from where it was placed61.6%0.1%
Malposition of device20.5%0.1%
Material deformation20.5%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant13234.6%
Implant pain143.7%
Inflammationinflammation143.7%
Appropriate clinical signs, symptoms and conditions term/code not available102.6%
Fistula82.1%
Abscessa collection of pus41%
Painpain, site not specified41%
Sinus perforation41%
Bone fracture(s)20.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobel Biocare N1 TiUltra TCC RP 4.8x9mmProduct code DZEAll MAUDE reports
Reports3823,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Nobel Biocare N1 TiUltra TCC RP 4.8x9mm reports

How many FDA reports name Nobel Biocare N1 TiUltra TCC RP 4.8x9mm?

382 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 190 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (64.4%), loss of osseointegration (23.6%), osseointegration problem (6.8%), migration (1.6%) and malposition of device (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Nobel Biocare N1 TiUltra TCC RP 4.8x9mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.